Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132943) titled 'A survey of patients with head and neck squamous cell carcinoma in China' on Sept. 20.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Beijing Cancer Hospital

Condition: Head and neck squamous cell carcinoma

Intervention: Locally advanced head and neck squamous cell carcinoma:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-23

Target Sample Size: Locally advanced head and neck squamous cell carcinoma:230;Recurrent/metastatic head and neck squamous cell carcinoma:154;

Countries of Recruitment: China

To know more, visit https://www...